Home/GlycoEra/Petra Duda, M.D., Ph.D.
PD

Petra Duda, M.D., Ph.D.

Chief Medical Officer

GlycoEra

Therapeutic Areas

GlycoEra Pipeline

DrugIndicationPhase
GE8820Autoimmune diseases driven by pathogenic IgG4 autoantibodiesPre-clinical